rs727503011
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001399.5(EDA):c.991C>T(p.Gln331*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. Q331Q) has been classified as Likely benign.
Frequency
Consequence
NM_001399.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- tooth agenesis, selective, X-linked, 1Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- X-linked hypohidrotic ectodermal dysplasiaInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
- tooth agenesisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| EDA | ENST00000374552.9 | c.991C>T | p.Gln331* | stop_gained | Exon 8 of 8 | 1 | NM_001399.5 | ENSP00000363680.4 | ||
| EDA | ENST00000374553.6 | c.985C>T | p.Gln329* | stop_gained | Exon 8 of 8 | 1 | ENSP00000363681.2 | |||
| EDA | ENST00000524573.5 | c.976C>T | p.Gln326* | stop_gained | Exon 8 of 8 | 1 | ENSP00000432585.1 | |||
| EDA | ENST00000616899.1 | c.595C>T | p.Gln199* | stop_gained | Exon 7 of 7 | 5 | ENSP00000481963.1 |
Frequencies
GnomAD3 genomes Cov.: 21
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 21
ClinVar
Submissions by phenotype
Hypohidrotic X-linked ectodermal dysplasia Pathogenic:2
For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the EDA protein in which other variant(s) (p.Ala367Valfs*10) have been determined to be pathogenic (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 163324). This premature translational stop signal has been observed in individual(s) with ectodermal dysplasia (PMID: 23553579). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln331*) in the EDA gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 61 amino acid(s) of the EDA protein. -
The Gln331X variant in EDA has been previously reported in one individual with X -linked hypohidrotic ectodermal dysplasia (XLHED; Dietz 2013). The Gln331X nonse nse variant leads to a premature termination codon at position 331, which is pre dicted to lead to a truncated or absent protein. Loss of function of the EDA gen e is an established disease mechanism in XLHED. In summary, this variant meets o ur criteria to be classified as pathogenic (http://pcpgm.partners.org/LMM). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at